JP2011525902A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011525902A5 JP2011525902A5 JP2011515663A JP2011515663A JP2011525902A5 JP 2011525902 A5 JP2011525902 A5 JP 2011525902A5 JP 2011515663 A JP2011515663 A JP 2011515663A JP 2011515663 A JP2011515663 A JP 2011515663A JP 2011525902 A5 JP2011525902 A5 JP 2011525902A5
- Authority
- JP
- Japan
- Prior art keywords
- pathogen
- immune response
- subject
- composition
- immunogenic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13314008P | 2008-06-25 | 2008-06-25 | |
| US61/133,140 | 2008-06-25 | ||
| PCT/IB2009/006260 WO2009156852A1 (en) | 2008-06-25 | 2009-06-25 | Rapid responses to delayed booster immunisations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011525902A JP2011525902A (ja) | 2011-09-29 |
| JP2011525902A5 true JP2011525902A5 (cg-RX-API-DMAC7.html) | 2012-08-09 |
| JP5712126B2 JP5712126B2 (ja) | 2015-05-07 |
Family
ID=41171092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011515663A Expired - Fee Related JP5712126B2 (ja) | 2008-06-25 | 2009-06-25 | 遅延型追加刺激免疫処置に対する迅速な応答 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9421251B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2310045A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5712126B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2729248A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009156852A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2804396C (en) | 2010-07-06 | 2021-06-29 | Novartis Ag | Liposomes with lipids having an advantageous pka-value for rna delivery |
| HRP20160805T1 (hr) | 2010-07-06 | 2016-08-12 | Glaxosmithkline Biologicals Sa | Imuniziranje velikih sisavaca malim dozama rna |
| LT3243526T (lt) | 2010-07-06 | 2020-02-10 | Glaxosmithkline Biologicals S.A. | Rnr pristatymas, skirtas keleto imuninio atsako paleidimui |
| SI3981427T1 (sl) | 2010-08-31 | 2022-08-31 | Glaxosmithkline Biologicals S.A. | Pegilirani liposomi za dostavo imunogen-kodirajoče RNA |
| CN103269713B (zh) | 2010-10-11 | 2016-01-20 | 诺华有限公司 | 抗原递送平台 |
| BR112013027229B1 (pt) | 2011-04-22 | 2020-10-27 | Wyeth Llc | polipeptídeo imunogênico isolado e seu uso, composição imunogênica e seu uso, célula recombinante ou progênie da mesma, e método de produção de uma toxina de clostridium difficile mutante |
| EP2729168A2 (en) | 2011-07-06 | 2014-05-14 | Novartis AG | Immunogenic compositions and uses thereof |
| EP3854413A1 (en) | 2011-07-06 | 2021-07-28 | GlaxoSmithKline Biologicals SA | Immunogenic combination compositions and uses thereof |
| BR122016023101B1 (pt) | 2012-10-21 | 2022-03-22 | Pfizer Inc | Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9923176D0 (en) | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
| ES2399386T3 (es) * | 2001-04-05 | 2013-04-01 | Novartis Vaccines And Diagnostics, Inc. | Aumento de la inmunidad de las mucosas tras sensibilización parenteral |
| US8080255B2 (en) | 2003-07-11 | 2011-12-20 | Novavax Inc. | Functional influenza virus like particles (VLPs) |
| TWI365074B (en) | 2004-10-07 | 2012-06-01 | Wyeth Corp | Multivalent avian influenza vaccines |
| CN101072585A (zh) * | 2004-11-01 | 2007-11-14 | 诺华疫苗和诊断公司 | 产生免疫应答的组合方法 |
| CA2602456A1 (en) * | 2005-03-23 | 2006-09-28 | Glaxosmithkline Biologicals S.A. | Composition |
| WO2007052057A2 (en) * | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics Srl | Adminstration routes for priming/boosting with influenza vaccines |
| EP1951302A2 (en) | 2005-11-04 | 2008-08-06 | Novartis Vaccines and Diagnostics S.r.l. | Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant |
| WO2007130330A2 (en) | 2006-05-01 | 2007-11-15 | Technovax, Inc. | Polyvalent influenza virus-like particle (vlp) compositions |
| KR101696727B1 (ko) | 2006-07-17 | 2017-01-16 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 인플루엔자 백신 |
| US20080014217A1 (en) | 2006-07-17 | 2008-01-17 | Emmanuel Jules Hanon | Influenza vaccine |
| GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
-
2009
- 2009-06-25 JP JP2011515663A patent/JP5712126B2/ja not_active Expired - Fee Related
- 2009-06-25 WO PCT/IB2009/006260 patent/WO2009156852A1/en not_active Ceased
- 2009-06-25 US US12/999,848 patent/US9421251B2/en not_active Expired - Fee Related
- 2009-06-25 CA CA2729248A patent/CA2729248A1/en not_active Abandoned
- 2009-06-25 EP EP09769663A patent/EP2310045A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011525902A5 (cg-RX-API-DMAC7.html) | ||
| Kim et al. | Influenza vaccines: Past, present, and future | |
| JP6308500B2 (ja) | 強化された免疫賦活化剤 | |
| Alving et al. | Adjuvants for human vaccines | |
| Tregoning et al. | Adjuvanted influenza vaccines | |
| Levitz et al. | Beyond empiricism: informing vaccine development through innate immunity research | |
| Mori et al. | The vaccine adjuvant alum inhibits IL‐12 by promoting PI 3 kinase signaling while chitosan does not inhibit IL‐12 and enhances T h1 and T h17 responses | |
| Yusuf et al. | Current prospects and future challenges for nasal vaccine delivery | |
| Skene et al. | Saponin-adjuvanted particulate vaccines for clinical use | |
| Smith et al. | Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines | |
| Demirjian et al. | Safety and efficacy of neonatal vaccination | |
| CN109364244B (zh) | 黏膜佐剂和递送系统 | |
| de Haan et al. | Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration | |
| JP2003523310A (ja) | 新規インフルエンザウイルスワクチン組成物 | |
| Dehghan et al. | Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants | |
| TW200722101A (en) | Novel composition | |
| JP5712126B2 (ja) | 遅延型追加刺激免疫処置に対する迅速な応答 | |
| Cheong et al. | Epigallocatechin-3-gallate as a novel vaccine adjuvant | |
| Jones et al. | Protollin™: a novel adjuvant for intranasal vaccines | |
| JP2015524802A5 (cg-RX-API-DMAC7.html) | ||
| JP2015529677A5 (cg-RX-API-DMAC7.html) | ||
| Krashias et al. | Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer | |
| de Veer et al. | New developments in vaccine research—unveiling the secret of vaccine adjuvants | |
| RU2017140856A (ru) | Стратегия вакцинации против вируса свиного гриппа вакциной на основе наночастиц | |
| Glenn et al. | Safety and immunogenicity of an influenza vaccine A/H5N1 (A/Vietnam/1194/2004) when coadministered with a heat-labile enterotoxin (LT) adjuvant patch |